Join CDI at the 2013 User Group Meeting,
Aug 26 - 28, 2013. This year's event will feature sessions on disease modeling, tissue engineering, toxicology, and drug discovery. See the agenda...
CDI’s iCell Cardiomyocytes were discussed during a recent American Journal of Physiology podcast. Authors describe published research detailing the electrophysiological characterization of iCell Cardiomyocytes.
The Power of iPS Cell Technology: Any cell type. Any genetic background. Any quantity. These cells deliver. Read more...
With 100+ employees and >700 patents, CDI manufactures human iPS cell-derived cell types with the quality, quantity, and purity required for basic life science and drug discovery research. Read more...
Apr 5, 2013
Foundation Fighting Blindness
Stem Cell Pioneers Creating Retinal Patch to Restore Vision
Mar 21, 2013
CDI Press Release
Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
Aug 26 - 28, 2013
CDI User Group Meeting
iCell Endothelial Cells
Have a unique genotype? MyCell Products provide a complete suite of iPS cell reprogramming, genetic engineering, and cell differentiation services to meet your research needs.